VEGFA and Best vitelliform macular dystrophy: CNV occurrence since the diagnosis of BVMD also was similar in both groups: eyes treated with an anti-VEGF agent, 5.9 ± 10.0 years (range, 0–40.0 years) versus eyes not treated with an anti-VEGF agent, 8.9 ± 15.1 years (range, 0–63.1 years; t = 0.81; P = 0.42, unpaired t test with Welch’s correction).